Weekly aerobic exercise volume over time for the DHA and placebo groups combined (n  by Claire M. Douglas (21238238)

Subjects:

Weekly resistance training frequency over time for the DHA and placebo groups combined (n  by Claire M. Douglas (21238238)

Subjects:

Quality of life scores at baseline (week 0) and end of chemotherapy (week 18) in the DHA and placebo groups. by Claire M. Douglas (21238238)

Subjects:

Participant demographic and clinical characteristics. by Claire M. Douglas (21238238)

Subjects:

Quality of life scores at baseline (week 0) and the end of chemotherapy (week 18) in participants that met (≥ 150 minutes/week) or did not meet (< 150 minutes/week) WHO’s aerobic e... by Claire M. Douglas (21238238)

Subjects:

Flow of participants through the DHA WIN RCT. Abbreviations: Docosahexaenoic acid (DHA), Docosahexaenoic acid for Women with Breast Cancer in the Neoadjuvant Setting (DHA WIN), ran... by Claire M. Douglas (21238238)

Subjects:

Quality of life scores at baseline (week 0) and the end of chemotherapy (week 18) in participants that met (≥ 2 times/week) or did not meet (< 2 times/week) WHO’s resistance traini... by Claire M. Douglas (21238238)

Subjects:

Theoretical framework. by Dinku Mechal (21273002)

“…For quantitative part, pretested a self-administered five-point Likert scale questionnaire was used and analyzed using SPSS® -version 26. Assumptions of linear multivariate regression were checked and the level of significance determined at a 95% CI and p-value <0.05. …”

Supplementary file survey questioner annex. by Dinku Mechal (21273002)

“…For quantitative part, pretested a self-administered five-point Likert scale questionnaire was used and analyzed using SPSS® -version 26. Assumptions of linear multivariate regression were checked and the level of significance determined at a 95% CI and p-value <0.05. …”

Flow diagram of different experiments and the study process. by Omid Mehrpour (9385929)

Subjects:

The mean scores of epidermis and dermis healing processes in burned rats after 10 and 21 days treatment with silver sulfadiazine 1% (silver), opium 0.05% (OP 0.05%), opium 0.5% (OP... by Omid Mehrpour (9385929)

Subjects:

The representative histological images of rat deep partial-thickness burns after 10 and 21 days of treatment with silver sulfadiazine 1% (SSD), opium 0.05% (OP0.05%), opium 0.5% (O... by Omid Mehrpour (9385929)

Subjects:

The concentration of inflammatory parameters (TNF-α and IL-10) in serum (a and b) and burned skin samples (c) of different experimental groups on day 2 and 10. by Omid Mehrpour (9385929)

Subjects:

The wound appearance of different groups during the period of study (a) and the percentage of wound reduction in treated groups on different days (b). by Omid Mehrpour (9385929)

Subjects:

Serum concentrations of malondialdehyde (a) and super oxide dismutase (b) and NOx (nitrate +nitrite) (c) in different experimental groups on day 2 and 10. by Omid Mehrpour (9385929)

Subjects:

The concentrations of malondialdehyde (a), super oxide dismutase (b), and NOx (nitrate +nitrite)(c) in the burned skin samples of different experimental groups on day 2 and 10. by Omid Mehrpour (9385929)

Subjects:

Renal (urea and creatinine) (a, b) and Liver function (ALT and AST) (c, d) test in serums of different experimental groups and body weight changes (e) on day 10. by Omid Mehrpour (9385929)

Subjects:

Dam and pup body and brain weights. by Adrienne J. Bradley (20861948)

Subjects:

Increased Iba-1 in mouse pups exposed to Pg-OMV during pregnancy. by Adrienne J. Bradley (20861948)

Subjects:

ELISA and RT-qPCR evaluation of cytokines in the embryonic mouse brain. by Adrienne J. Bradley (20861948)

Subjects: